Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/11/2012WO2012136839A1 Dry formulation and pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
10/11/2012WO2012136838A1 Pharmaceutical composition comprising fesoterodine
10/11/2012WO2012136816A2 Pharmaceutical composition
10/11/2012WO2012136369A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma
10/11/2012WO2012136224A2 Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
10/11/2012WO2012136125A1 Compound dual-release capsule formulation comprised of bromodihydroartemisinin and a fe2+ agent
10/11/2012WO2012135959A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012WO2012135951A1 Oral enzyme compositions for intestinal delivery
10/11/2012WO2012106118A3 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
10/11/2012WO2012105797A3 Structure having nanoantenna and method for manufacturing same
10/11/2012WO2012104867A3 Gel film for treating corneal endothelial cell defects
10/11/2012WO2012091748A3 Therapeutic agent reservoir delivery system
10/11/2012WO2012085888A3 Polyelectrolyte complex, process for its manufacture and use thereof
10/11/2012WO2012085171A3 Pharmaceutical compositions of pyridinium and quinolinium derivatives
10/11/2012WO2012067491A3 Compositions comprising extracts obtained from oil palm based materials for providing anti -inflammatory effects and method of producing thereof
10/11/2012WO2012007159A3 Novel gastro-retentive dosage forms
10/11/2012US20120259022 Pharmaceutical compositions providing enhanced drug concentrations
10/11/2012US20120258939 Pharmaceutical manufacturing process
10/11/2012US20120258177 Microcapsules comprising benzoyl peroxide and topical compositions comprising them
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258175 Encapsulated bacteriophage formulation
10/11/2012US20120258174 Methods for Treating Bacterial Infection
10/11/2012US20120258173 Functionally-Coated Multilayer Tablets
10/11/2012US20120258172 Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
10/11/2012US20120258171 Composition comprising fesoterodine and fiber
10/11/2012US20120258170 Pharmaceutical co-crystals of quercetin
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258168 Methods and compositions to promote ocular health
10/11/2012US20120258167 Oral pharmaceutical composition
10/11/2012US20120258166 Rifaximin compositions and method of use
10/11/2012US20120258165 Phospholipid derivative and ph-responsive liposomes
10/11/2012US20120258164 Transdermal granisetron
10/11/2012US20120258163 Tyrosine Kinase Microspheres
10/11/2012US20120258162 Controlled delivery of molecules from a biointerface
10/11/2012US20120258161 Implantable polymeric device for sustained release of dopamine agonist
10/11/2012US20120258160 Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
10/11/2012US20120258159 Malleable, biodegradable hemostatic agent
10/11/2012US20120258150 Particles comprising volatile materials and particle gas saturated solution processes for making same
10/11/2012US20120258149 Methods and Compositions for the Prevention and Treatment of Influenza
10/11/2012US20120258148 Endosseous implant
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258146 Method of treating organic diseases of nervous system, pschoorganic syndrome and encephalopathy
10/11/2012US20120258062 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
10/11/2012US20120258047 Epsilon-poly-lysine capsules
10/11/2012US20120258038 Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseases
10/11/2012CA2833425A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012CA2832556A1 Formulations with reduced viscosity
10/11/2012CA2832500A1 Pharmaceutical composition comprising fesoterodine
10/11/2012CA2832486A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma
10/11/2012CA2832443A1 Modulating bacterial mam polypeptides in pathogenic disease
10/11/2012CA2832303A1 Pharmaceutical preparation
10/11/2012CA2832300A1 Topical skin care formulations comprising plant extracts
10/11/2012CA2832130A1 Pharmaceutical composition
10/11/2012CA2831535A1 Oral enzyme compositions for intestinal delivery
10/11/2012CA2831480A1 Lipid-based nanoparticles
10/11/2012CA2830045A1 Healing composition for topical application
10/11/2012CA2829181A1 The treatment of viral infections
10/10/2012EP2508341A1 Compositions comprising elemental metals and uses therefor
10/10/2012EP2508207A1 Nanoparticles loaded with chemotherapeutic antitumoral Drug
10/10/2012EP2508206A1 Film coating agent for solid preparation, and solid preparation using same
10/10/2012EP2508205A2 Preserved compositions containing hyaluronic acid or a pharmaceutically- acceptable salt thereof and related methods
10/10/2012EP2508188A1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/10/2012EP2508187A1 Triflusal powder containing cyclodextrin as a stabilizing agent
10/10/2012EP2508175A1 Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
10/10/2012EP2508174A1 Pharmaceutical composition
10/10/2012EP2508173A1 Stabilized pharmaceutical composition comprising fesoterodine
10/10/2012EP2508172A1 Stable and uniform formulations of entecavir and preparation method thereof
10/10/2012EP2508171A1 Pharmaceutical magnetic nano-particle composition
10/10/2012EP2508170A1 Liposome of irinotecan or its hydrochloride and preparation method thereof
10/10/2012EP2508169A1 Polymersome and process for producing same
10/10/2012EP2507056A1 Conformable barrier sheet, methods, and device
10/10/2012EP2506880A1 Compositions comprising nonsteroidal anti - inflammatory drugs
10/10/2012EP2506879A1 Snalp formulations containing antioxidants
10/10/2012EP2506859A1 Microspheres of hydrolysed starch with endogenous, charged ligands
10/10/2012EP2506858A1 Starch derivative mixtures
10/10/2012EP2506857A1 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
10/10/2012EP2506842A2 Formulations, salts and polymorphs of transnorsertraline and uses thereof
10/10/2012EP2506841A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
10/10/2012EP2506839A2 Transdermal therapeutic system for the administration of peptides
10/10/2012EP2506838A1 Transdermal testosterone device and delivery
10/10/2012EP2506837A2 Spider silk particles for controlled and sustained delivery of compounds
10/10/2012EP2506836A2 Fexofenadine microcapsules and compositions containing them
10/10/2012EP2506835A1 Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
10/10/2012EP2506834A2 Circulation of components during microfluidization and/or homogenization of emulsions
10/10/2012EP2506833A2 Arranging interaction and back pressure chambers for microfluidization
10/10/2012EP2506832A2 Hydrophilic filtration during manufacture of vaccine adjuvants
10/10/2012EP2506831A2 Carboxyvinyl polymer-containing nanoparticle suspension
10/10/2012EP2506830A1 Ophthalmic emulsion
10/10/2012EP2506820A2 Integrated ingestible event marker system with pharmaceutical product
10/10/2012EP2506814A1 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
10/10/2012EP2506714A1 Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting
10/10/2012EP2263654B1 Compositions for improving the oral absorption of antimicrobial agents
10/10/2012CN1956733B Dietary supplement and method of processing same
10/10/2012CN1863519B Hydrogel compositions with an erodible backing member
10/10/2012CN1829482B Medicine box for treatment of dependence withdrawal
10/10/2012CN1822817B Inhalable formulations for treating pulmonary hypertension and methods of using same
10/10/2012CN1714861B Thymus penta peptide slow releasing micro ball and its preparing method
10/10/2012CN1689611B Production method of Qi invigorating blood maintaining particle
10/10/2012CN1678188B Nucleic acid compositions for stimulating immune responses
10/10/2012CN1304450B Novel insulin analogs with enhanced zinc binding
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 2991